Helen M. Boudreau

Helen M. Boudreau is an accomplished professional with a diverse background in economics and management. She holds a BA Summa Cum Laude in Economics from the University of Maryland and an MBA in General Management from the University of Virginia Darden School of Business.

Throughout her career, Helen has held key positions in renowned organizations across various industries. Her notable roles include Chief Operating Officer at the Bill & Melinda Gates Medical Research Institute, Chief Financial Officer at Proteostasis Therapeutics, Inc. (PTI), and CFO at Novartis Corporation.

Helen M. Boudreau has also served as a Board Member at prestigious companies such as Cara Therapeutics, Rallybio, Shattuck Labs, Premier Inc., Evaxion Biotech A/S, and Reunion Neuroscience. Her strategic involvement as a Board Member showcases her expertise in governance and decision-making.

Prior to her executive roles, Helen honed her skills in finance and management through positions such as Vice President Investor Relations at Novartis Corporation, Vice President Finance at Pfizer Global Research & Development, and Engagement Manager/Consultant at McKinsey & Company.

With a strong foundation in financial planning and analysis, strategic management, and commercial operations, Helen has consistently demonstrated her leadership capabilities and business acumen. Her extensive experience in diverse organizations highlights her adaptability and proficiency in navigating complex business landscapes.

Helen M. Boudreau's multifaceted career trajectory encompasses both corporate leadership roles and strategic advisory positions, reflecting her versatility and talent in driving organizational success. Her contributions to the healthcare, pharmaceutical, and finance sectors underscore her unique insights and expertise in these domains.